カテゴリー： GlobalInfoResearch, 世界

エキソソーム診断および治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Exosome Diagnostics and Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9102023）・商品コード：GIR9102023
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月16日（※2024年版があります。お問い合わせください）
・ページ数：122
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、エキソソーム診断および治療の世界市場について調べ、まとめました。種類別セグメントは、機器、試薬、ソフトウェア等、用途別セグメントは、診断、治療等に区分しました。エキソソーム診断および治療の世界市場概観、企業動向、企業別エキソソーム診断および治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・エキソソーム診断および治療の市場概観
・エキソソーム診断および治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・エキソソーム診断および治療の企業別販売動向、市場シェア、市場集中度、競争動向
・エキソソーム診断および治療の世界市場規模
・エキソソーム診断および治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・エキソソーム診断および治療のアメリカ市場規模推移
・エキソソーム診断および治療のカナダ市場規模推移
・エキソソーム診断および治療のメキシコ市場規模推移
・エキソソーム診断および治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・エキソソーム診断および治療のドイツ市場規模推移
・エキソソーム診断および治療のイギリス市場規模推移
・エキソソーム診断および治療のロシア市場規模推移
・エキソソーム診断および治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・エキソソーム診断および治療の日本市場規模推移
・エキソソーム診断および治療の中国市場規模推移
・エキソソーム診断および治療の韓国市場規模推移
・エキソソーム診断および治療のインド市場規模推移
・エキソソーム診断および治療の東南アジア市場規模推移
・エキソソーム診断および治療の南米市場分析（ブラジル、アルゼンチン等）
・エキソソーム診断および治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・エキソソーム診断および治療の種類別分析/販売量、売上、市場シェア（機器、試薬、ソフトウェア）
・エキソソーム診断および治療の用途別分析/市場規模（診断、治療）
・エキソソーム診断および治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・エキソソーム診断および治療の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Exosomes play a key role in facilitating cell-to-cell communication in the cancer prognosis. It suppresses the immune function by inducing apoptosis of activated cytotoxic T cells, which enable tumor progression in the human body.

Scope of the Report:
The global Exosome Diagnostics and Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Exosome Diagnostics and Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Exosome Diagnostics and Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Exosome Diagnostics and Therapeutics market by product type and applications/end industries.

Market Segment by Companies, this report covers
Aethlon Medical(US)
Exosome Diagnostics(US)
NanoSomix Inc.(US)
Thermo Fisher Scientific (US)
Malvern Instruments (UK)
System Biosciences(US)
NX Pharmagen (US)
Sistemic Inc(UK)
Capricor Therapeutics (US)
Exiqon A/S (Denmark)

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Instrument
Reagent
Software

Market Segment by Applications, can be divided into
Diagnostic
Therapeutic

【レポートの目次】

Table of Contents

1 Exosome Diagnostics and Therapeutics Market Overview
1.1 Product Overview and Scope of Exosome Diagnostics and Therapeutics
1.2 Classification of Exosome Diagnostics and Therapeutics by Types
1.2.1 Global Exosome Diagnostics and Therapeutics Revenue Comparison by Types (2019-2024)
1.2.2 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Types in 2018
1.2.3 Instrument
1.2.4 Reagent
1.2.5 Software
1.3 Global Exosome Diagnostics and Therapeutics Market by Application
1.3.1 Global Exosome Diagnostics and Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Global Exosome Diagnostics and Therapeutics Market by Regions
1.4.1 Global Exosome Diagnostics and Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Exosome Diagnostics and Therapeutics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Exosome Diagnostics and Therapeutics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Exosome Diagnostics and Therapeutics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Exosome Diagnostics and Therapeutics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Exosome Diagnostics and Therapeutics Status and Prospect (2014-2024)
1.5 Global Market Size of Exosome Diagnostics and Therapeutics (2014-2024)
2 Manufacturers Profiles
2.1 Aethlon Medical(US)
2.1.1 Business Overview
2.1.2 Exosome Diagnostics and Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.2 Exosome Diagnostics(US)
2.2.1 Business Overview
2.2.2 Exosome Diagnostics and Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.3 NanoSomix Inc.(US)
2.3.1 Business Overview
2.3.2 Exosome Diagnostics and Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.4 Thermo Fisher Scientific (US)
2.4.1 Business Overview
2.4.2 Exosome Diagnostics and Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.5 Malvern Instruments (UK)
2.5.1 Business Overview
2.5.2 Exosome Diagnostics and Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.6 System Biosciences(US)
2.6.1 Business Overview
2.6.2 Exosome Diagnostics and Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.7 NX Pharmagen (US)
2.7.1 Business Overview
2.7.2 Exosome Diagnostics and Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.8 Sistemic Inc(UK)
2.8.1 Business Overview
2.8.2 Exosome Diagnostics and Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.9 Capricor Therapeutics (US)
2.9.1 Business Overview
2.9.2 Exosome Diagnostics and Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.10 Exiqon A/S (Denmark)
2.10.1 Business Overview
2.10.2 Exosome Diagnostics and Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Exosome Diagnostics and Therapeutics Market Competition, by Players
3.1 Global Exosome Diagnostics and Therapeutics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Exosome Diagnostics and Therapeutics Players Market Share
3.2.2 Top 10 Exosome Diagnostics and Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Exosome Diagnostics and Therapeutics Market Size by Regions
4.1 Global Exosome Diagnostics and Therapeutics Revenue and Market Share by Regions
4.2 North America Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
4.3 Europe Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
4.5 South America Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
5 North America Exosome Diagnostics and Therapeutics Revenue by Countries
5.1 North America Exosome Diagnostics and Therapeutics Revenue by Countries (2014-2019)
5.2 USA Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
5.3 Canada Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
5.4 Mexico Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
6 Europe Exosome Diagnostics and Therapeutics Revenue by Countries
6.1 Europe Exosome Diagnostics and Therapeutics Revenue by Countries (2014-2019)
6.2 Germany Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
6.3 UK Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
6.4 France Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
6.5 Russia Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
6.6 Italy Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Exosome Diagnostics and Therapeutics Revenue by Countries
7.1 Asia-Pacific Exosome Diagnostics and Therapeutics Revenue by Countries (2014-2019)
7.2 China Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
7.3 Japan Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
7.4 Korea Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
7.5 India Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
8 South America Exosome Diagnostics and Therapeutics Revenue by Countries
8.1 South America Exosome Diagnostics and Therapeutics Revenue by Countries (2014-2019)
8.2 Brazil Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
8.3 Argentina Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
8.4 Colombia Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Exosome Diagnostics and Therapeutics by Countries
9.1 Middle East and Africa Exosome Diagnostics and Therapeutics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
9.3 UAE Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
9.4 Egypt Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
9.6 South Africa Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
10 Global Exosome Diagnostics and Therapeutics Market Segment by Type
10.1 Global Exosome Diagnostics and Therapeutics Revenue and Market Share by Type (2014-2019)
10.2 Global Exosome Diagnostics and Therapeutics Market Forecast by Type (2019-2024)
10.3 Instrument Revenue Growth Rate (2014-2024)
10.4 Reagent Revenue Growth Rate (2014-2024)
10.5 Software Revenue Growth Rate (2014-2024)
11 Global Exosome Diagnostics and Therapeutics Market Segment by Application
11.1 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Application (2014-2019)
11.2 Exosome Diagnostics and Therapeutics Market Forecast by Application (2019-2024)
11.3 Diagnostic Revenue Growth (2014-2019)
11.4 Therapeutic Revenue Growth (2014-2019)
12 Global Exosome Diagnostics and Therapeutics Market Size Forecast (2019-2024)
12.1 Global Exosome Diagnostics and Therapeutics Market Size Forecast (2019-2024)
12.2 Global Exosome Diagnostics and Therapeutics Market Forecast by Regions (2019-2024)
12.3 North America Exosome Diagnostics and Therapeutics Revenue Market Forecast (2019-2024)
12.4 Europe Exosome Diagnostics and Therapeutics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Exosome Diagnostics and Therapeutics Revenue Market Forecast (2019-2024)
12.6 South America Exosome Diagnostics and Therapeutics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Exosome Diagnostics and Therapeutics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Exosome Diagnostics and Therapeutics Picture
Table Product Specifications of Exosome Diagnostics and Therapeutics
Table Global Exosome Diagnostics and Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Exosome Diagnostics and Therapeutics Revenue Market Share by Types in 2018
Figure Instrument Picture
Figure Reagent Picture
Figure Software Picture
Table Global Exosome Diagnostics and Therapeutics Revenue (Million USD) by Application (2014-2024)
Figure Exosome Diagnostics and Therapeutics Revenue Market Share by Applications in 2018
Figure Diagnostic Picture
Figure Therapeutic Picture
Table Global Market Exosome Diagnostics and Therapeutics Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Exosome Diagnostics and Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Exosome Diagnostics and Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Exosome Diagnostics and Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Exosome Diagnostics and Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Exosome Diagnostics and Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Exosome Diagnostics and Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Table Aethlon Medical(US) Basic Information, Manufacturing Base and Competitors
Table Aethlon Medical(US) Exosome Diagnostics and Therapeutics Type and Applications
Table Aethlon Medical(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Exosome Diagnostics(US) Basic Information, Manufacturing Base and Competitors
Table Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Type and Applications
Table Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table NanoSomix Inc.(US) Basic Information, Manufacturing Base and Competitors
Table NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Type and Applications
Table NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Thermo Fisher Scientific (US) Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Type and Applications
Table Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Malvern Instruments (UK) Basic Information, Manufacturing Base and Competitors
Table Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Type and Applications
Table Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table System Biosciences(US) Basic Information, Manufacturing Base and Competitors
Table System Biosciences(US) Exosome Diagnostics and Therapeutics Type and Applications
Table System Biosciences(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table NX Pharmagen (US) Basic Information, Manufacturing Base and Competitors
Table NX Pharmagen (US) Exosome Diagnostics and Therapeutics Type and Applications
Table NX Pharmagen (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Sistemic Inc(UK) Basic Information, Manufacturing Base and Competitors
Table Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Type and Applications
Table Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Capricor Therapeutics (US) Basic Information, Manufacturing Base and Competitors
Table Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Type and Applications
Table Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Exiqon A/S (Denmark) Basic Information, Manufacturing Base and Competitors
Table Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Type and Applications
Table Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Global Exosome Diagnostics and Therapeutics Revenue (Million USD) by Players (2014-2019)
Table Global Exosome Diagnostics and Therapeutics Revenue Share by Players (2014-2019)
Figure Global Exosome Diagnostics and Therapeutics Revenue Share by Players in 2017
Figure Global Exosome Diagnostics and Therapeutics Revenue Share by Players in 2018
Figure Global Top 5 Players Exosome Diagnostics and Therapeutics Revenue Market Share in 2018
Figure Global Top 10 Players Exosome Diagnostics and Therapeutics Revenue Market Share in 2018
Figure Global Exosome Diagnostics and Therapeutics Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Exosome Diagnostics and Therapeutics Revenue (Million USD) by Regions (2014-2019)
Table Global Exosome Diagnostics and Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Exosome Diagnostics and Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Exosome Diagnostics and Therapeutics Revenue Market Share by Regions in 2018
Figure North America Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure Europe Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure South America Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Table North America Exosome Diagnostics and Therapeutics Revenue by Countries (2014-2019)
Table North America Exosome Diagnostics and Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Exosome Diagnostics and Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Exosome Diagnostics and Therapeutics Revenue Market Share by Countries in 2018
Figure USA Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure Canada Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure Mexico Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Table Europe Exosome Diagnostics and Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Europe Exosome Diagnostics and Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Europe Exosome Diagnostics and Therapeutics Revenue Market Share by Countries in 2018
Figure Germany Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure UK Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure France Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure Russia Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure Italy Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Exosome Diagnostics and Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Exosome Diagnostics and Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Exosome Diagnostics and Therapeutics Revenue Market Share by Countries in 2018
Figure China Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure Japan Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure Korea Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure India Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Table South America Exosome Diagnostics and Therapeutics Revenue by Countries (2014-2019)
Table South America Exosome Diagnostics and Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Exosome Diagnostics and Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Exosome Diagnostics and Therapeutics Revenue Market Share by Countries in 2018
Figure Brazil Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure Argentina Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure Colombia Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Exosome Diagnostics and Therapeutics Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Exosome Diagnostics and Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Exosome Diagnostics and Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Exosome Diagnostics and Therapeutics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure UAE Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure Egypt Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure Nigeria Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Figure South Africa Exosome Diagnostics and Therapeutics Revenue and Growth Rate (2014-2019)
Table Global Exosome Diagnostics and Therapeutics Revenue (Million USD) by Type (2014-2019)
Table Global Exosome Diagnostics and Therapeutics Revenue Share by Type (2014-2019)
Figure Global Exosome Diagnostics and Therapeutics Revenue Share by Type (2014-2019)
Figure Global Exosome Diagnostics and Therapeutics Revenue Share by Type in 2019
Table Global Exosome Diagnostics and Therapeutics Revenue Forecast by Type (2019-2024)
Figure Global Exosome Diagnostics and Therapeutics Market Share Forecast by Type (2019-2024)
Figure Global Instrument Revenue Growth Rate (2014-2019)
Figure Global Reagent Revenue Growth Rate (2014-2019)
Figure Global Software Revenue Growth Rate (2014-2019)
Table Global Exosome Diagnostics and Therapeutics Revenue by Application (2014-2019)
Table Global Exosome Diagnostics and Therapeutics Revenue Share by Application (2014-2019)
Figure Global Exosome Diagnostics and Therapeutics Revenue Share by Application (2014-2019)
Figure Global Exosome Diagnostics and Therapeutics Revenue Share by Application in 2019
Table Global Exosome Diagnostics and Therapeutics Revenue Forecast by Application (2019-2024)
Figure Global Exosome Diagnostics and Therapeutics Market Share Forecast by Application (2019-2024)
Figure Global Diagnostic Revenue Growth Rate (2014-2019)
Figure Global Therapeutic Revenue Growth Rate (2014-2019)
Figure Global Exosome Diagnostics and Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Exosome Diagnostics and Therapeutics Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Exosome Diagnostics and Therapeutics Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Exosome Diagnostics and Therapeutics Revenue Market Forecast (2019-2024)
Figure Europe Exosome Diagnostics and Therapeutics Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Exosome Diagnostics and Therapeutics Revenue Market Forecast (2019-2024)
Figure South America Exosome Diagnostics and Therapeutics Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Exosome Diagnostics and Therapeutics Revenue Market Forecast (2019-2024)


【掲載企業】

Aethlon Medical(US)、Exosome Diagnostics(US)、NanoSomix Inc.(US)、Thermo Fisher Scientific (US)、Malvern Instruments (UK)、System Biosciences(US)、NX Pharmagen (US)、Sistemic Inc(UK)、Capricor Therapeutics (US)、Exiqon A/S (Denmark)、

★調査レポート[エキソソーム診断および治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9102023)販売に関する免責事項を必ずご確認ください。
★調査レポート[エキソソーム診断および治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 糖鎖生物学（診断と治療）の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102025 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、糖鎖生物学（診断と治療）の世界市場について調べ、まとめました。種類別セグメントは、診断、治療学等、用途別セグメントは、クリニック、病院、その他等に区分しました。糖鎖生物学（診断と治療）の世界市場概観、企業動向、企業別糖鎖生物学（診断と治療）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・糖鎖生物学（診断と治療）の市場概観 ・糖鎖生物学（診断と治療）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・糖鎖生物学（診断と治療）の企業別販売動向、市場シェア、市場集中度、競争動向 ・糖鎖生物学（診断と治療）の世界市場規模 ・糖鎖生物学（診断と治療）の北米市場分析（アメリカ、カナダ、メキシコ等） ・糖鎖生物学（診断と治療）のアメリカ市場規模推移 ・糖鎖生物学（診断と治療）のカナダ市場規模推移 ・糖鎖生物学（診断と治療）のメキシコ市場規模推移 ・糖鎖生物学（診断と治療）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Glycobiology is the study of the structure, biosynthesis, and biology of saccharides that are widely distributed in nature. Glycobiology is the study of the structure, function and biology of carbohydrates, also called glycans. Glycans are present in every living organism. Glycobiology is a rapidly growing field in biology, with relevance to biomedicine, biotechnology and basic research. Scope of the Report: Glycans are diverse, complex molecules and their functions are determined by their unique structures. Effective enzymatic tools and analytical techniques are required to properly elucidate glycan structure, which can then be correlated to a specific function. Glycosylation defines the adhesive...
  • 脂質異常症治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101945 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、脂質異常症治療薬の世界市場について調べ、まとめました。種類別セグメントは、スタチン、非スタチン、併用薬等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。脂質異常症治療薬の世界市場概観、企業動向、企業別脂質異常症治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・脂質異常症治療薬の市場概観 ・脂質異常症治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・脂質異常症治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・脂質異常症治療薬の世界市場規模 ・脂質異常症治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・脂質異常症治療薬のアメリカ市場規模推移 ・脂質異常症治療薬のカナダ市場規模推移 ・脂質異常症治療薬のメキシコ市場規模推移 ・脂質異常症治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Dyslipidemia is an abnormal amount of lipids (e.g. triglycerides, cholesterol and/or fat phospholipids) in the blood. In this report, Dyslipidemia Therapeutics are divided into statins, non-statins and combinations drugs. Scope of the Report: The global Dyslipidemia Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play...
  • mRNAワクチンおよび治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100023 / GlobalInfoResearch / 2019年10月9日 / 本調査レポートは、mRNAワクチンおよび治療薬の世界市場について調べ、まとめました。種類別セグメントは、感染症、がん、その他等、用途別セグメントは、病院、研究機関等に区分しました。mRNAワクチンおよび治療薬の世界市場概観、企業動向、企業別mRNAワクチンおよび治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・mRNAワクチンおよび治療薬の市場概観 ・mRNAワクチンおよび治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・mRNAワクチンおよび治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・mRNAワクチンおよび治療薬の世界市場規模 ・mRNAワクチンおよび治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・mRNAワクチンおよび治療薬のアメリカ市場規模推移 ・mRNAワクチンおよび治療薬のカナダ市場規模推移 ・mRNAワクチンおよび治療薬のメキシコ市場規模推移 ・mRNAワクチンおよび治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global mRNA Vaccine And Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of mRNA Vaccine And Therapeutics. Europe also play important...
  • 体外診断システムの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103417 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、体外診断システムの世界市場について調べ、まとめました。種類別セグメントは、血液検査、尿検査等、用途別セグメントは、分子診断、臨床化学、糖尿病およびグルコース検査、免疫化学、血液学、その他等に区分しました。体外診断システムの世界市場概観、企業動向、企業別体外診断システムシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・体外診断システムの市場概観 ・体外診断システムの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・体外診断システムの企業別販売動向、市場シェア、市場集中度、競争動向 ・体外診断システムの世界市場規模 ・体外診断システムの北米市場分析（アメリカ、カナダ、メキシコ等） ・体外診断システムのアメリカ市場規模推移 ・体外診断システムのカナダ市場規模推移 ・体外診断システムのメキシコ市場規模推移 ・体外診断システムのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...In vitro diagnostics are diagnostic tests that that can detect diseases, conditions or infections. Scope of the Report: The global In Vitro Diagnostics Systems market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might...
  • 薬物乱用治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103563 / GlobalInfoResearch / 2019年9月27日 / 本調査レポートは、薬物乱用治療薬の世界市場について調べ、まとめました。種類別セグメントは、オピオイド中毒、タバコ/ニコチン中毒、アルコール依存症等、用途別セグメントは、病院＆クリニック、住宅（病院以外）等に区分しました。薬物乱用治療薬の世界市場概観、企業動向、企業別薬物乱用治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・薬物乱用治療薬の市場概観 ・薬物乱用治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・薬物乱用治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・薬物乱用治療薬の世界市場規模 ・薬物乱用治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・薬物乱用治療薬のアメリカ市場規模推移 ・薬物乱用治療薬のカナダ市場規模推移 ・薬物乱用治療薬のメキシコ市場規模推移 ・薬物乱用治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Substance Abuse can be defined as habitually, dependence of an individual on any drugs, which turns into an addiction. Opioid, alcohol, tobacco and cigarettes are some of the common, drugs which has been misused leading to drugs addictions. In recent past, many products have been launched in market for treatment and management of substance abuse. Some commonly used drug for treatment of substance abuse are Disulfiram, Acamprosate, Naltrexone, Nicotine Replacement Treatment, Methadone, and Buprenorphine. Scope of the Report: The global Substance Abuse Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD...
  • 結核診断および治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102008 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、結核診断および治療の世界市場について調べ、まとめました。種類別セグメントは、皮膚試験、実験室試験等、用途別セグメントは、病院、クリニック、その他等に区分しました。結核診断および治療の世界市場概観、企業動向、企業別結核診断および治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・結核診断および治療の市場概観 ・結核診断および治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・結核診断および治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・結核診断および治療の世界市場規模 ・結核診断および治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・結核診断および治療のアメリカ市場規模推移 ・結核診断および治療のカナダ市場規模推移 ・結核診断および治療のメキシコ市場規模推移 ・結核診断および治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Tuberculosis refer to the infectious bacterial disease characterized by the growth of nodules (tubercles) in the tissues, especially the lungs. Scope of the Report: The global Tuberculosis Diagnostics and Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored....

    • ◆H&Iグローバルリサーチのお客様（例）◆